Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Randomized, Controlled Study of Repeat Dose Sustained Release Lidocaine for Treatment of Chronic Scrotal Pain
- First Posted Date
- 2023-01-31
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Sustained Therapeutics Inc.
- Target Recruit Count
- 63
- Registration Number
- NCT05707208
- Locations
- 🇨🇦
Prostate Cancer Centre - Rockyview Hospital, Calgary, Alberta, Canada
🇨🇦Kelowna General Hospital Clinical Research Department, Kelowna, British Columbia, Canada
🇨🇦Vancouver Prostate Centre, Vancouver, British Columbia, Canada
News
No news found